A novel mutation in glial fibrillary acidic protein gene in a patient with Alexander disease.

Abstract

Alexander disease is a rare, progressive, leukoencephalopathy whose hallmark is the widespread accumulation of Rosenthal fibers. The most common form affects infants and young children, and is characterized by progressive failure of central myelination, usually leading to death before adulthood. Definitive diagnosis of Alexander disease has required biopsy or autopsy to demonstrate the presence of Rosenthal fibers. However, missense mutations in the coding region of the glial fibrillary acidic protein (GFAP) gene have recently been associated with a high percentage of pathologically proven cases. Here we report that a 10-year-old Japanese patient who showed clinical signs of Alexander disease is heterozygous for a C to T transition in which predicts a novel A244V amino acid substitution in the conserved 2A alpha-helix domain of GFAP. The nucleotide change was not found in 65 normal individuals (130 alleles). These results provide further support for a causative role for GFAP mutations in Alexander disease, and suggest DNA sequencing as an alternative diagnostic to biopsy.

Statistics

050'03'05'07'09'11'13'15'17
Citations per Year

132 Citations

Semantic Scholar estimates that this publication has 132 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Aoki2001ANM, title={A novel mutation in glial fibrillary acidic protein gene in a patient with Alexander disease.}, author={Yoichi Aoki and Kazuhiro Haginoya and Masanori Munakata and Hitoshi Yokoyama and Tomoko Nishio and Nobuhiko Togashi and Takaaki Ito and Yuka Suzuki and Shigeo Kure and Kazuie Iinuma and Michaela Brenner and Yoichi Matsubara}, journal={Neuroscience letters}, year={2001}, volume={312 2}, pages={71-4} }